SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Kintara Therapeutics, Inc. – ‘S-4/A’ on 7/1/20 – ‘EX-101.SCH’

On:  Wednesday, 7/1/20, at 7:59pm ET   ·   As of:  7/2/20   ·   Accession #:  1193125-20-185478   ·   File #:  333-239215

Previous ‘S-4’:  ‘S-4’ on 6/16/20   ·   Next & Latest:  ‘S-4’ on 5/13/24   ·   12 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/02/20  DelMar Pharmaceuticals, Inc.      S-4/A       7/01/20   76:11M                                    Donnelley … Solutions/FA

Pre-Effective Amendment to Registration of Securities Issued in a Merger   —   Form S-4
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-4/A       Pre-Effective Amendment to Registration of          HTML   3.41M 
                Securities Issued in a Business-Combination                      
                Transaction                                                      
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML     31K 
 3: EX-8.1      Opinion of Counsel re: Tax Matters                  HTML     29K 
 4: EX-10.43    Material Contract                                   HTML    102K 
 5: EX-23.3     Consent of Experts or Counsel                       HTML     23K 
 6: EX-23.4     Consent of Experts or Counsel                       HTML     22K 
 7: EX-99.1     Miscellaneous Exhibit                               HTML     29K 
 8: EX-99.2     Miscellaneous Exhibit                               HTML     26K 
 9: EX-99.3     Miscellaneous Exhibit                               HTML     23K 
10: EX-99.4     Miscellaneous Exhibit                               HTML     23K 
17: R1          Cover                                               HTML     38K 
18: R2          Condensed Consolidated Interim Balance Sheets       HTML     86K 
19: R3          Condensed Consolidated Interim Balance Sheets       HTML     45K 
                (Parenthetical)                                                  
20: R4          Condensed Consolidated Interim Statements of        HTML     68K 
                Operations                                                       
21: R5          Condensed Consolidated Interim Statements of        HTML    143K 
                Stockholders' Equity                                             
22: R6          Condensed Consolidated Interim Statements of Cash   HTML     88K 
                Flows                                                            
23: R7          Nature of Operations, Corporate History, and Going  HTML     44K 
                Concern                                                          
24: R8          Significant accounting policies                     HTML     91K 
25: R9          Valent Technologies LLC agreements                  HTML     29K 
26: R10         Derivative liabilities                              HTML     64K 
27: R11         Stockholders' equity                                HTML    218K 
28: R12         Related party transactions                          HTML     29K 
29: R13         Current and deferred income taxes                   HTML     46K 
30: R14         Commitments and contingencies                       HTML     29K 
31: R15         Supplementary statement of cash flows information   HTML     35K 
32: R16         Financial risk management                           HTML     39K 
33: R17         Subsequent events                                   HTML     46K 
34: R18         Financial instruments                               HTML     34K 
35: R19         Significant accounting policies (Policies)          HTML    142K 
36: R20         Significant accounting policies (Tables)            HTML     30K 
37: R21         Derivative liabilities (Tables)                     HTML     60K 
38: R22         Stockholders' equity (Tables)                       HTML    185K 
39: R23         Current and deferred income taxes (Tables)          HTML     44K 
40: R24         Supplementary statement of cash flows information   HTML     34K 
                (Tables)                                                         
41: R25         Financial risk management (Tables)                  HTML     33K 
42: R26         Nature of Operations, Corporate History, and Going  HTML     42K 
                Concern (Detail)                                                 
43: R27         Significant Accounting Policies (Detail)            HTML     69K 
44: R28         Significant accounting policies - Schedule of       HTML     30K 
                derivative liabilities under the fair value                      
                hierarchy (Detail)                                               
45: R29         Valent Technologies LLC Agreements - Additional     HTML     44K 
                Information (Detail)                                             
46: R30         Derivative Liabilities - Additional Information     HTML     56K 
                (Detail)                                                         
47: R31         Derivative Liabilities - Schedule of derivative     HTML     43K 
                liabilities (Detail)                                             
48: R32         Derivative Liabilities - Schedule of derivative     HTML     47K 
                liabilities 1 (Detail)                                           
49: R33         Stockholders' Equity (Deficiency) (Textual)         HTML    133K 
                (Detail)                                                         
50: R34         Stockholders' Equity (Deficiency) (Textual 2)       HTML     86K 
                (Detail)                                                         
51: R35         Stockholders' Equity (Deficiency) (Textual 3)       HTML    131K 
                (Detail)                                                         
52: R36         Stockholders' equity (deficiency) - Schedule of     HTML     55K 
                outstanding under the legacy plan (Detail)                       
53: R37         Stockholders' Equity (Deficiency) - Schedule of     HTML     49K 
                valuation assumptions using a Black-Scholes                      
                pricing model (Detail)                                           
54: R38         Stockholders' equity (deficiency) - Summary of      HTML    106K 
                stock options currently outstanding and                          
                exercisable (Detail)                                             
55: R39         Stockholders' Equity (Deficiency) - (Textual 4)     HTML     84K 
                (Detail)                                                         
56: R40         Stockholders' equity (deficiency) - Schedule of     HTML     34K 
                stock-based compensation expense (Detail)                        
57: R41         Stockholders' equity (deficiency) - Summary of      HTML     51K 
                unvested stock options (Detail)                                  
58: R42         Stockholders' Equity (Deficiency) - Schedule of     HTML     75K 
                warrants (Detail)                                                
59: R43         Stockholders' Equity (Deficiency) - Schedule of     HTML     46K 
                warrants (Parenthetical) (Detail)                                
60: R44         Stockholders' Equity (Deficiency - Summary of       HTML     39K 
                changes in outstanding warrants (Detail)                         
61: R45         Stockholders' Equity (Deficiency) - Summary of      HTML     86K 
                outstanding warrants (Detail)                                    
62: R46         Related Party Transactions - Additional             HTML     32K 
                Information (Detail)                                             
63: R47         Current and Deferred Income Taxes - Components of   HTML     50K 
                future tax assets and deferred tax liabilities                   
                (Detail)                                                         
64: R48         Current and Deferred Income Taxes - Additional      HTML     52K 
                Information (Detail)                                             
65: R49         Current and Deferred Income Taxes - Schedule of     HTML     47K 
                difference between income tax rate and statutory                 
                income tax rate (Detail)                                         
66: R50         Commitments and Contingencies - Additional          HTML     33K 
                Information (Detail)                                             
67: R51         Supplementary Statement of Cash Flows Information   HTML     40K 
                - Schedule of supplementary statement of cash                    
                flows information (Detail)                                       
68: R52         Financial Risk Management - Additional Information  HTML     50K 
                (Detail)                                                         
69: R53         Financial Risk Management - Schedule of balances    HTML     32K 
                in foreign currencies (Detail)                                   
70: R54         Financial Risk Management - Schedule of fair value  HTML     32K 
                of off-balance sheet risks (Detail)                              
71: R55         Subsequent Events - Additional Information          HTML    112K 
                (Detail)                                                         
72: R56         Stockholders' Equity - Schedule of Conversion of    HTML     36K 
                Series B Preferred stock to common stock (Detail)                
73: R57         Financial Instruments - Additional Information      HTML     26K 
                (Detail)                                                         
75: XML         IDEA XML File -- Filing Summary                      XML    132K 
74: EXCEL       IDEA Workbook of Financial Reports                  XLSX    113K 
11: EX-101.INS  XBRL Instance -- dmpi-20200331                       XML   2.13M 
13: EX-101.CAL  XBRL Calculations -- dmpi-20200331_cal               XML    145K 
14: EX-101.DEF  XBRL Definitions -- dmpi-20200331_def                XML    762K 
15: EX-101.LAB  XBRL Labels -- dmpi-20200331_lab                     XML   1.39M 
16: EX-101.PRE  XBRL Presentations -- dmpi-20200331_pre              XML   1.05M 
12: EX-101.SCH  XBRL Schema -- dmpi-20200331                         XSD    236K 
76: ZIP         XBRL Zipped Folder -- 0001193125-20-185478-xbrl      Zip    205K

‘EX-101.SCH’   —   XBRL Schema — dmpi-20200331

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- DFIN Xcelerate Taxonomy Schema - https://www.dfinsolutions.com/ -->
<!-- Version: 6.23.6 -->
<!-- Round: 6de19f8b-67c8-43ee-a1d8-0dbb4d03da08 -->
<!-- Creation date: 2020-07-01T18:02:12Z -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:dmpi="http://www.delmarpharma.com/20200331" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" targetNamespace="http://www.delmarpharma.com/20200331" elementFormDefault="qualified" attributeFormDefault="unqualified">
<annotation>
<appinfo>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/Cover" id="Cover">
<link:definition> 101 - Document - Cover </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/StatementOfFinancialPositionClassified" id="StatementOfFinancialPositionClassified">
<link:definition> 103 - Statement - Condensed Consolidated Interim Balance Sheets </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical" id="StatementOfFinancialPositionClassifiedParen">
<link:definition> 104 - Statement - Condensed Consolidated Interim Balance Sheets (Parenthetical) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/StatementOfIncomeAlternative" id="StatementOfIncomeAlternative">
<link:definition> 105 - Statement - Condensed Consolidated Interim Statements of Operations </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome" id="Role_ci-StatementOfShareholdersEquityAndOtherComprehensiveIncome">
<link:definition> 106 - Statement - Condensed Consolidated Interim Statements of Stockholders' Equity </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/StatementOfCashFlowsIndirect" id="StatementOfCashFlowsIndirect">
<link:definition> 107 - Statement - Condensed Consolidated Interim Statements of Cash Flows </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" id="Role_NotesToFinancialStatementsNatureOfOperations">
<link:definition> 108 - Disclosure - Nature of Operations, Corporate History, and Going Concern </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<link:definition> 109 - Disclosure - Significant accounting policies </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsValentTechnologiesLlcTextBlock" id="Role_NotesToFinancialStatementsValentTechnologiesLlcTextBlock">
<link:definition> 110 - Disclosure - Valent Technologies LLC agreements </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="Role_NotesToFinancialStatementsDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<link:definition> 111 - Disclosure - Derivative liabilities </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock" id="Role_NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock">
<link:definition> 112 - Disclosure - Stockholders' equity </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock" id="Role_NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock">
<link:definition> 113 - Disclosure - Related party transactions </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock" id="Role_NotesToFinancialStatementsIncomeTaxDisclosureTextBlock">
<link:definition> 114 - Disclosure - Current and deferred income taxes </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" id="Role_NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock">
<link:definition> 115 - Disclosure - Commitments and contingencies </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsCashFlowSupplementalDisclosuresTextBlock" id="Role_NotesToFinancialStatementsCashFlowSupplementalDisclosuresTextBlock">
<link:definition> 116 - Disclosure - Supplementary statement of cash flows information </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsConcentrationRiskDisclosureTextBlock" id="Role_NotesToFinancialStatementsConcentrationRiskDisclosureTextBlock">
<link:definition> 117 - Disclosure - Financial risk management </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock" id="Role_NotesToFinancialStatementsSubsequentEventsTextBlock">
<link:definition> 118 - Disclosure - Subsequent events </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlock" id="Role_NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlock">
<link:definition> 119 - Disclosure - Financial instruments </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlockPolicies" id="Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlockPolicies">
<link:definition> 120 - Disclosure - Significant accounting policies (Policies) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlockTables" id="Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlockTables">
<link:definition> 121 - Disclosure - Significant accounting policies (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlockTables" id="Role_NotesToFinancialStatementsDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlockTables">
<link:definition> 122 - Disclosure - Derivative liabilities (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables" id="Role_NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables">
<link:definition> 123 - Disclosure - Stockholders' equity (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables" id="Role_NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables">
<link:definition> 124 - Disclosure - Current and deferred income taxes (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsCashFlowSupplementalDisclosuresTextBlockTables" id="Role_NotesToFinancialStatementsCashFlowSupplementalDisclosuresTextBlockTables">
<link:definition> 125 - Disclosure - Supplementary statement of cash flows information (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/NotesToFinancialStatementsConcentrationRiskDisclosureTextBlockTables" id="Role_NotesToFinancialStatementsConcentrationRiskDisclosureTextBlockTables">
<link:definition> 126 - Disclosure - Financial risk management (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureNatureOfOperationsCorporateHistoryAndGoingConcern" id="DisclosureNatureOfOperationsCorporateHistoryAndGoingConcern">
<link:definition> 127 - Disclosure - Nature of Operations, Corporate History, and Going Concern (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureSignificantAccountingPolicies" id="DisclosureSignificantAccountingPolicies">
<link:definition> 128 - Disclosure - Significant Accounting Policies (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfDerivativeLiabilitiesUnderTheFairValueHierarchy" id="DisclosureSignificantAccountingPoliciesScheduleOfDerivativeLiabilitiesUnderTheFairValueHierarchy">
<link:definition> 129 - Disclosure - Significant accounting policies - Schedule of derivative liabilities under the fair value hierarchy (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureValentTechnologiesLLCAgreementsAdditionalInformation" id="DisclosureValentTechnologiesLLCAgreementsAdditionalInformation">
<link:definition> 130 - Disclosure - Valent Technologies LLC Agreements - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureDerivativeLiabilitiesAdditionalInformation" id="DisclosureDerivativeLiabilitiesAdditionalInformation">
<link:definition> 131 - Disclosure - Derivative Liabilities - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureDerivativeLiabilitiesScheduleOfDerivativeLiabilities" id="DisclosureDerivativeLiabilitiesScheduleOfDerivativeLiabilities">
<link:definition> 132 - Disclosure - Derivative Liabilities - Schedule of derivative liabilities (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureDerivativeLiabilitiesScheduleOfDerivativeLiabilities1" id="DisclosureDerivativeLiabilitiesScheduleOfDerivativeLiabilities1">
<link:definition> 133 - Disclosure - Derivative Liabilities - Schedule of derivative liabilities 1 (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureStockholdersEquityDeficiencyTextual" id="DisclosureStockholdersEquityDeficiencyTextual">
<link:definition> 134 - Disclosure - Stockholders' Equity (Deficiency) (Textual) (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureStockholdersEquityDeficiencyTextual2" id="DisclosureStockholdersEquityDeficiencyTextual2">
<link:definition> 135 - Disclosure - Stockholders' Equity (Deficiency) (Textual 2) (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureStockholdersEquityDeficiencyTextual3" id="DisclosureStockholdersEquityDeficiencyTextual3">
<link:definition> 136 - Disclosure - Stockholders' Equity (Deficiency) (Textual 3) (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureStockholdersEquitydeficiencyScheduleOfOutstandingUnderTheLegacyPlan" id="DisclosureStockholdersEquitydeficiencyScheduleOfOutstandingUnderTheLegacyPlan">
<link:definition> 137 - Disclosure - Stockholders' equity (deficiency) - Schedule of outstanding under the legacy plan (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureStockholdersEquityDeficiencyScheduleOfValuationAssumptionsUsingABlackScholesPricingModel" id="DisclosureStockholdersEquityDeficiencyScheduleOfValuationAssumptionsUsingABlackScholesPricingModel">
<link:definition> 138 - Disclosure - Stockholders' Equity (Deficiency) - Schedule of valuation assumptions using a Black-Scholes pricing model (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureStockholdersEquitydeficiencySummaryOfStockOptionsCurrentlyOutstandingAndExercisable" id="DisclosureStockholdersEquitydeficiencySummaryOfStockOptionsCurrentlyOutstandingAndExercisable">
<link:definition> 139 - Disclosure - Stockholders' equity (deficiency) - Summary of stock options currently outstanding and exercisable (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureStockholdersEquityDeficiencyTextual4" id="DisclosureStockholdersEquityDeficiencyTextual4">
<link:definition> 140 - Disclosure - Stockholders' Equity (Deficiency) - (Textual 4) (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureStockholdersEquitydeficiencyScheduleOfStockbasedCompensationExpense" id="DisclosureStockholdersEquitydeficiencyScheduleOfStockbasedCompensationExpense">
<link:definition> 141 - Disclosure - Stockholders' equity (deficiency) - Schedule of stock-based compensation expense (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureStockholdersEquitydeficiencySummaryOfUnvestedStockOptions" id="DisclosureStockholdersEquitydeficiencySummaryOfUnvestedStockOptions">
<link:definition> 142 - Disclosure - Stockholders' equity (deficiency) - Summary of unvested stock options (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureStockholdersEquityDeficiencyScheduleOfWarrants" id="DisclosureStockholdersEquityDeficiencyScheduleOfWarrants">
<link:definition> 143 - Disclosure - Stockholders' Equity (Deficiency) - Schedule of warrants (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureStockholdersEquityDeficiencyScheduleOfWarrantsParenthetical" id="DisclosureStockholdersEquityDeficiencyScheduleOfWarrantsParenthetical">
<link:definition> 144 - Disclosure - Stockholders' Equity (Deficiency) - Schedule of warrants (Parenthetical) (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureStockholdersEquityDeficiencySummaryOfChangesInOutstandingWarrants" id="DisclosureStockholdersEquityDeficiencySummaryOfChangesInOutstandingWarrants">
<link:definition> 145 - Disclosure - Stockholders' Equity (Deficiency - Summary of changes in outstanding warrants (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureStockholdersEquityDeficiencySummaryOfOutstandingWarrants" id="DisclosureStockholdersEquityDeficiencySummaryOfOutstandingWarrants">
<link:definition> 146 - Disclosure - Stockholders' Equity (Deficiency) - Summary of outstanding warrants (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation" id="DisclosureRelatedPartyTransactionsAdditionalInformation">
<link:definition> 147 - Disclosure - Related Party Transactions - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureCurrentAndDeferredIncomeTaxesComponentsOfFutureTaxAssetsAndDeferredTaxLiabilities" id="DisclosureCurrentAndDeferredIncomeTaxesComponentsOfFutureTaxAssetsAndDeferredTaxLiabilities">
<link:definition> 148 - Disclosure - Current and Deferred Income Taxes - Components of future tax assets and deferred tax liabilities (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureCurrentAndDeferredIncomeTaxesAdditionalInformation" id="DisclosureCurrentAndDeferredIncomeTaxesAdditionalInformation">
<link:definition> 149 - Disclosure - Current and Deferred Income Taxes - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureCurrentAndDeferredIncomeTaxesScheduleOfDifferenceBetweenIncomeTaxRateAndStatutoryIncomeTaxRate" id="DisclosureCurrentAndDeferredIncomeTaxesScheduleOfDifferenceBetweenIncomeTaxRateAndStatutoryIncomeTaxRate">
<link:definition> 150 - Disclosure - Current and Deferred Income Taxes - Schedule of difference between income tax rate and statutory income tax rate (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation" id="DisclosureCommitmentsAndContingenciesAdditionalInformation">
<link:definition> 151 - Disclosure - Commitments and Contingencies - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureSupplementaryStatementOfCashFlowsInformationScheduleOfSupplementaryStatementOfCashFlowsInformation" id="DisclosureSupplementaryStatementOfCashFlowsInformationScheduleOfSupplementaryStatementOfCashFlowsInformation">
<link:definition> 152 - Disclosure - Supplementary Statement of Cash Flows Information - Schedule of supplementary statement of cash flows information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureFinancialRiskManagementAdditionalInformation" id="DisclosureFinancialRiskManagementAdditionalInformation">
<link:definition> 153 - Disclosure - Financial Risk Management - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureFinancialRiskManagementScheduleOfBalancesInForeignCurrencies" id="DisclosureFinancialRiskManagementScheduleOfBalancesInForeignCurrencies">
<link:definition> 154 - Disclosure - Financial Risk Management - Schedule of balances in foreign currencies (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureFinancialRiskManagementScheduleOfFairValueOfOffbalanceSheetRisks" id="DisclosureFinancialRiskManagementScheduleOfFairValueOfOffbalanceSheetRisks">
<link:definition> 155 - Disclosure - Financial Risk Management - Schedule of fair value of off-balance sheet risks (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation" id="DisclosureSubsequentEventsAdditionalInformation">
<link:definition> 156 - Disclosure - Subsequent Events - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureStockholdersEquityScheduleOfConversionOfSeriesBPreferredStockToCommonStock" id="DisclosureStockholdersEquityScheduleOfConversionOfSeriesBPreferredStockToCommonStock">
<link:definition> 157 - Disclosure - Stockholders' Equity - Schedule of Conversion of Series B Preferred stock to common stock (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.delmarpharma.com/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformation" id="DisclosureFinancialInstrumentsAdditionalInformation">
<link:definition> 158 - Disclosure - Financial Instruments - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:href="dmpi-20200331_cal.xml" xlink:title="Calculation Links, all"/>
<link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:href="dmpi-20200331_def.xml" xlink:title="Definition Links, all"/>
<link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:href="dmpi-20200331_lab.xml" xlink:title="Label Links, all"/>
<link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:href="dmpi-20200331_pre.xml" xlink:title="Presentation Links, all"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd"/>
<import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
<import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
<element name="AccrualsForResearchAndDevelopmentExpensesAndClinicalTrialsPolicytextBlock" id="dmpi_AccrualsForResearchAndDevelopmentExpensesAndClinicalTrialsPolicytextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AdjustmentOfWarrantsGrantedForServicesShares" id="dmpi_AdjustmentOfWarrantsGrantedForServicesShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AgentFourMember" id="dmpi_AgentFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AgentMember" id="dmpi_AgentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AgentOneMember" id="dmpi_AgentOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AgentThreeMember" id="dmpi_AgentThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AgentTwoMember" id="dmpi_AgentTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AgreementsAxis" id="dmpi_AgreementsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem"/>
<element name="AgreementsDomain" id="dmpi_AgreementsDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AmendedArticlesOfIncorporation" id="dmpi_AmendedArticlesOfIncorporation" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="BidPrice" id="dmpi_BidPrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="BusinessCombinationStockPurchaseWarrantsAsPercentageOfValueOfSharesIssued" id="dmpi_BusinessCombinationStockPurchaseWarrantsAsPercentageOfValueOfSharesIssued" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="BusinessCombinationSuccessFeeAsPercentageOfCommonSharesIssued" id="dmpi_BusinessCombinationSuccessFeeAsPercentageOfCommonSharesIssued" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CADMember" id="dmpi_CADMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CanadianScientificResearchAndDevelopmentMember" id="dmpi_CanadianScientificResearchAndDevelopmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ClassOfWarrantOrRightExercised" id="dmpi_ClassOfWarrantOrRightExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ClassOfWarrantOrRightIssued" id="dmpi_ClassOfWarrantOrRightIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ClinicalDevelopmentResearchDeposits" id="dmpi_ClinicalDevelopmentResearchDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ColumbiaMember" id="dmpi_ColumbiaMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommitmentsAndContingenciesTextualAbstract" id="dmpi_CommitmentsAndContingenciesTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommonStockIssuedUnder2017Plan" id="dmpi_CommonStockIssuedUnder2017Plan" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConversionOffSeriesbPreferredStockToCommonStockShares" id="dmpi_ConversionOffSeriesbPreferredStockToCommonStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConversionOfPreferredStockSeriesBtoCommonstock" id="dmpi_ConversionOfPreferredStockSeriesBtoCommonstock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConversionOfPreferredStockSeriesBtoCommonstockShares" id="dmpi_ConversionOfPreferredStockSeriesBtoCommonstockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConversionOfSeriesBPreferredStockSharesToCommonStock" id="dmpi_ConversionOfSeriesBPreferredStockSharesToCommonStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConversionOfSeriesbPreferredStockToCommonStock" id="dmpi_ConversionOfSeriesbPreferredStockToCommonStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConversionOfSeriesBPreferredStockToCommonStockShares" id="dmpi_ConversionOfSeriesBPreferredStockToCommonStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConvertedExercisePricesMember" id="dmpi_ConvertedExercisePricesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CurrentAndFutureIncomeTaxesTextualsAbstract" id="dmpi_CurrentAndFutureIncomeTaxesTextualsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DeferredFinancingCosts" id="dmpi_DeferredFinancingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DeferredTaxAssetsFinancingCost" id="dmpi_DeferredTaxAssetsFinancingCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DeferredTaxLiabilitiesScientificResearchAndDevelopment" id="dmpi_DeferredTaxLiabilitiesScientificResearchAndDevelopment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DerivativesAndHedgesAdditionalTextualAbstract" id="dmpi_DerivativesAndHedgesAdditionalTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DescriptionOfStockOptionGrants" id="dmpi_DescriptionOfStockOptionGrants" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="EmployeeStockOptionOneMember" id="dmpi_EmployeeStockOptionOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExchangeAgreementMember" id="dmpi_ExchangeAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExerciseAndExchangeOfWarrants" id="dmpi_ExerciseAndExchangeOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExerciseAndExchangeOfWarrantsInShares" id="dmpi_ExerciseAndExchangeOfWarrantsInShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExerciseAndExchangeOfWarrantsIssueCosts" id="dmpi_ExerciseAndExchangeOfWarrantsIssueCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExerciseOfWarrantsForCash" id="dmpi_ExerciseOfWarrantsForCash" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExerciseOfWarrantsForCashShares" id="dmpi_ExerciseOfWarrantsForCashShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExerciseOfWarrantsIssuedToInvestorShares" id="dmpi_ExerciseOfWarrantsIssuedToInvestorShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceEighteenMember" id="dmpi_ExercisePriceEighteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceEightMember" id="dmpi_ExercisePriceEightMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceElevenMember" id="dmpi_ExercisePriceElevenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceFifteenMember" id="dmpi_ExercisePriceFifteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceFiveMember" id="dmpi_ExercisePriceFiveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceFourMember" id="dmpi_ExercisePriceFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceFourteenMember" id="dmpi_ExercisePriceFourteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceMember" id="dmpi_ExercisePriceMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceNineMember" id="dmpi_ExercisePriceNineMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceNineteenMember" id="dmpi_ExercisePriceNineteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceOfCaMember" id="dmpi_ExercisePriceOfCaMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceOneMember" id="dmpi_ExercisePriceOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceSevenMember" id="dmpi_ExercisePriceSevenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceSeventeenMember" id="dmpi_ExercisePriceSeventeenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceSixMember" id="dmpi_ExercisePriceSixMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceSixteenMember" id="dmpi_ExercisePriceSixteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceTenMember" id="dmpi_ExercisePriceTenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceThirteenMember" id="dmpi_ExercisePriceThirteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceThreeMember" id="dmpi_ExercisePriceThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceTwelveMember" id="dmpi_ExercisePriceTwelveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceTwentyMember" id="dmpi_ExercisePriceTwentyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExercisePriceTwoMember" id="dmpi_ExercisePriceTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExpenseRelatedToThePerformanceStockUnits" id="dmpi_ExpenseRelatedToThePerformanceStockUnits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExpiryOfWarrants" id="dmpi_ExpiryOfWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExpiryOfWarrantsForServices" id="dmpi_ExpiryOfWarrantsForServices" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueOfWarrant" id="dmpi_FairValueOfWarrant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FinalClosingDate" id="dmpi_FinalClosingDate" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FinancialInstrumentsDetailsTextualAbstract" id="dmpi_FinancialInstrumentsDetailsTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FinancialRiskManagementTextualAbstract" id="dmpi_FinancialRiskManagementTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FormerChairmanMember" id="dmpi_FormerChairmanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FormerPresidentAndChiefOperatingOfficerMember" id="dmpi_FormerPresidentAndChiefOperatingOfficerMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FullyDilutedSharesOfCommonStockPercentage" id="dmpi_FullyDilutedSharesOfCommonStockPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GrossProceedsFromExerciseOfWarrants" id="dmpi_GrossProceedsFromExerciseOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GroupOneMember" id="dmpi_GroupOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GroupTwoMember" id="dmpi_GroupTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IncomeTaxReconciliationPermanentDifferences" id="dmpi_IncomeTaxReconciliationPermanentDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IncreaseDecreaseInFairValueOfWarrantsIssuedForServices" id="dmpi_IncreaseDecreaseInFairValueOfWarrantsIssuedForServices" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IncreaseDecreaseInTaxesAndOtherReceivables" id="dmpi_IncreaseDecreaseInTaxesAndOtherReceivables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IncreaseDecreaseRetainedEarningsDeficit" id="dmpi_IncreaseDecreaseRetainedEarningsDeficit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IncreaseSharesOfCommonStockAvailableForIssuance" id="dmpi_IncreaseSharesOfCommonStockAvailableForIssuance" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="InvestorFourMember" id="dmpi_InvestorFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="InvestorOneMember" id="dmpi_InvestorOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="InvestorThreeMember" id="dmpi_InvestorThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="InvestorTwoMember" id="dmpi_InvestorTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="InvestorWarrantMember" id="dmpi_InvestorWarrantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="InvestorWarrants" id="dmpi_InvestorWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="InvestorWarrantsMember" id="dmpi_InvestorWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuanceOfAgentWarrants" id="dmpi_IssuanceOfAgentWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuanceOfAgentWarrantsSharesOne" id="dmpi_IssuanceOfAgentWarrantsSharesOne" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuanceOfAgentWarrantsSharesOneValue" id="dmpi_IssuanceOfAgentWarrantsSharesOneValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuanceOfInvestorWarrantsShares" id="dmpi_IssuanceOfInvestorWarrantsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuanceOfInvestorWarrantsSharesOne" id="dmpi_IssuanceOfInvestorWarrantsSharesOne" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuanceOfInvestorWarrantsSharesOneValue" id="dmpi_IssuanceOfInvestorWarrantsSharesOneValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuanceOfSharesAndWarrantsNetOfIssueCost" id="dmpi_IssuanceOfSharesAndWarrantsNetOfIssueCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuanceOfSharesAndWarrantsNetOfIssueCostShare" id="dmpi_IssuanceOfSharesAndWarrantsNetOfIssueCostShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuanceOfStockForServices" id="dmpi_IssuanceOfStockForServices" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuanceOfWarrantsBalance" id="dmpi_IssuanceOfWarrantsBalance" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuanceOfWarrantsCurrentPortion" id="dmpi_IssuanceOfWarrantsCurrentPortion" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuanceOfWarrantsLongTermPortion" id="dmpi_IssuanceOfWarrantsLongTermPortion" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssueCostsInAccountsPayable" id="dmpi_IssueCostsInAccountsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuedForServicesFiveMember" id="dmpi_IssuedForServicesFiveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuedForServicesFourMember" id="dmpi_IssuedForServicesFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuedForServicesMember" id="dmpi_IssuedForServicesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuedForServicesOneMember" id="dmpi_IssuedForServicesOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuedForServicesSixMember" id="dmpi_IssuedForServicesSixMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuedForServicesThreeMember" id="dmpi_IssuedForServicesThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuedForServicesTwoMember" id="dmpi_IssuedForServicesTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IssuedWarrantsForServices" id="dmpi_IssuedWarrantsForServices" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="LegacyPlanDescription" id="dmpi_LegacyPlanDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="LiquidityRiskMaximumExposure" id="dmpi_LiquidityRiskMaximumExposure" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="LiquidityRiskMember" id="dmpi_LiquidityRiskMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ManufacturingAndClinicalStudyManagementRelatedCost" id="dmpi_ManufacturingAndClinicalStudyManagementRelatedCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MergerAgreementDescription" id="dmpi_MergerAgreementDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MergerAgreementExpectedCompletionPeriod" id="dmpi_MergerAgreementExpectedCompletionPeriod" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MergerAgreementMember" id="dmpi_MergerAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NatureOfOperationCorporateHistoryAndLiquidityRiskTextualAbstract" id="dmpi_NatureOfOperationCorporateHistoryAndLiquidityRiskTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NatureOfOperationsAbstract" id="dmpi_NatureOfOperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NetProceedsFromPublicOffering" id="dmpi_NetProceedsFromPublicOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NoncashDerivativeIssueCosts" id="dmpi_NoncashDerivativeIssueCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NonCashIssueCosts" id="dmpi_NonCashIssueCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfFundedWarrantsOfSharesIssuedInUnderwrittenOffering" id="dmpi_NumberOfFundedWarrantsOfSharesIssuedInUnderwrittenOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfSharesExerciseOfPreFundedWarrants" id="dmpi_NumberOfSharesExerciseOfPreFundedWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfWarrantsCashlessExchangeOfInvestorWarrants" id="dmpi_NumberOfWarrantsCashlessExchangeOfInvestorWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfWarrantsExerciseAndExchangeOfInvestorWarrants" id="dmpi_NumberOfWarrantsExerciseAndExchangeOfInvestorWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfWarrantsExerciseofInvestorWarrantsForCash" id="dmpi_NumberOfWarrantsExerciseofInvestorWarrantsForCash" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfWarrantsIssuedToInvestor" id="dmpi_NumberOfWarrantsIssuedToInvestor" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfWarrantsIssuedToInvestorAndAgentsCost" id="dmpi_NumberOfWarrantsIssuedToInvestorAndAgentsCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfWarrantsIssuedToInvestorAndAgentsShares" id="dmpi_NumberOfWarrantsIssuedToInvestorAndAgentsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="OfficersAndDirectorsMember" id="dmpi_OfficersAndDirectorsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="OmnibusIncentivePlanMember" id="dmpi_OmnibusIncentivePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PaymentOfWarrantExpenses" id="dmpi_PaymentOfWarrantExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PerformanceStockUnitsDescription" id="dmpi_PerformanceStockUnitsDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PerformanceStockUnitsMember" id="dmpi_PerformanceStockUnitsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PerformanceStockUnitsPolicyTextBlock" id="dmpi_PerformanceStockUnitsPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PeriodicLeaseRentPayment" id="dmpi_PeriodicLeaseRentPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PlacementAgentMember" id="dmpi_PlacementAgentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="Plan2017Member" id="dmpi_Plan2017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PreferredStockSpecialVotingSharesIssued" id="dmpi_PreferredStockSpecialVotingSharesIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PreFundedWarrantsMember" id="dmpi_PreFundedWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ProceedsFromIssuanceOfSharesAndWarrants" id="dmpi_ProceedsFromIssuanceOfSharesAndWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ProceedsFromIssuanceOfWarrantsNet" id="dmpi_ProceedsFromIssuanceOfWarrantsNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ProceedsFromWarrantExercisesGross" id="dmpi_ProceedsFromWarrantExercisesGross" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ReclassificationOfDerivativeLiabilityToEquity" id="dmpi_ReclassificationOfDerivativeLiabilityToEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ReclassificationOfDerivativeLiabilityToEquityUponAmendmentOfDividendWarrants" id="dmpi_ReclassificationOfDerivativeLiabilityToEquityUponAmendmentOfDividendWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ReclassificationOfDerivativeLiabilityToEquityUponExerciseOfWarrants" id="dmpi_ReclassificationOfDerivativeLiabilityToEquityUponExerciseOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ReclassificationToEquityUponExerciseOfWarrants" id="dmpi_ReclassificationToEquityUponExerciseOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="RelatedPartyTransactionsTextualAbstract" id="dmpi_RelatedPartyTransactionsTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="RevaluedDeferredTaxAssets" id="dmpi_RevaluedDeferredTaxAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ReverseAcquisitionDescription" id="dmpi_ReverseAcquisitionDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ReverseStockSplitPolicyTextBlock" id="dmpi_ReverseStockSplitPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ScheduleOfDerivativeLiabilitiesRollForward" id="dmpi_ScheduleOfDerivativeLiabilitiesRollForward" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ScheduleOfOutstandingWarrantsTableTextBlock" id="dmpi_ScheduleOfOutstandingWarrantsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SeriesBConvertiblePreferredSharesMember" id="dmpi_SeriesBConvertiblePreferredSharesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SeriesbPreferredStockDividend" id="dmpi_SeriesbPreferredStockDividend" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SeriesbPreferredStockDividendShares" id="dmpi_SeriesbPreferredStockDividendShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SeriesOnePreferredStockMember" id="dmpi_SeriesOnePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SeriesPreferredStockDividends" id="dmpi_SeriesPreferredStockDividends" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SeriesTwoPreferredStockMember" id="dmpi_SeriesTwoPreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SharebasedCompensationArrangementBySharebasedPaymentAwardModifiedExercisePeriodNumber" id="dmpi_SharebasedCompensationArrangementBySharebasedPaymentAwardModifiedExercisePeriodNumber" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod" id="dmpi_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIntrinsicValue" id="dmpi_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIntrinsicValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm" id="dmpi_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsForfeitedWeightedAverageExercisePrice" id="dmpi_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsForfeitedWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsGrantedWeightedAverageExercisePrice" id="dmpi_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsGrantedWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsUnvestedWeightedAverageExercisePrice" id="dmpi_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsUnvestedWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsVestedWeightedAverageExercisePrice" id="dmpi_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsVestedWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SharebasedPaymentArrangementAdditionalCost" id="dmpi_SharebasedPaymentArrangementAdditionalCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SharesForServicesPolicyTextBlock" id="dmpi_SharesForServicesPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SignificantAccountingPoliciesTextualAbstract" id="dmpi_SignificantAccountingPoliciesTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockholderApprovalMember" id="dmpi_StockholderApprovalMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockholdersEquityTextualAbstract" id="dmpi_StockholdersEquityTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockIssuedDuringPeriodSharesCashlessExerciseOfWarrantsOne" id="dmpi_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrantsOne" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockIssuedDuringPeriodSharesWarrantsExercisedForCash" id="dmpi_StockIssuedDuringPeriodSharesWarrantsExercisedForCash" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockIssuedDuringPeriodShareWarrantExercised" id="dmpi_StockIssuedDuringPeriodShareWarrantExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockIssuedDuringPeriodValueCashlessExerciseOfWarrantsOne" id="dmpi_StockIssuedDuringPeriodValueCashlessExerciseOfWarrantsOne" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockIssuedDuringPeriodValueReverseStockSplits" id="dmpi_StockIssuedDuringPeriodValueReverseStockSplits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockIssuedDuringPeriodValueWarrantsExercisedForCash" id="dmpi_StockIssuedDuringPeriodValueWarrantsExercisedForCash" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockIssuedDuringPeriodWarrantsIssuedForServices" id="dmpi_StockIssuedDuringPeriodWarrantsIssuedForServices" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockOptionModificationDescription" id="dmpi_StockOptionModificationDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SubsequentEventsTextualAbstract" id="dmpi_SubsequentEventsTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SummaryOfChangesOfOutstandingWarrantsTableTextBlock" id="dmpi_SummaryOfChangesOfOutstandingWarrantsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TaxesAndOtherReceivablesCurrent" id="dmpi_TaxesAndOtherReceivablesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TotalNumberOfCommonStockAvailableShares" id="dmpi_TotalNumberOfCommonStockAvailableShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TwoThousandAndSeventeenEquityIncentivePlanMember" id="dmpi_TwoThousandAndSeventeenEquityIncentivePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TwoZeroOneEightPublicOfferingMember" id="dmpi_TwoZeroOneEightPublicOfferingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TwoZeroOneFiveAgentWarrantsMember" id="dmpi_TwoZeroOneFiveAgentWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TwoZeroOneNineInvestorWarrantsMember" id="dmpi_TwoZeroOneNineInvestorWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TwoZeroOneNinePublicOfferingMember" id="dmpi_TwoZeroOneNinePublicOfferingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TwoZeroOneThreeInvestorWarrantsMember" id="dmpi_TwoZeroOneThreeInvestorWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TypeOfCurrencyAxis" id="dmpi_TypeOfCurrencyAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem"/>
<element name="TypeOfCurrencyDomain" id="dmpi_TypeOfCurrencyDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="UnauditedInterimFinancialDataPolicyTextBlock" id="dmpi_UnauditedInterimFinancialDataPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="UncategorizedAbstract" id="dmpi_UncategorizedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="UnderwriterOneMember" id="dmpi_UnderwriterOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="UnderwriterWarrantsIssuedInUnderwrittenOffering" id="dmpi_UnderwriterWarrantsIssuedInUnderwrittenOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="UnderwritingOfferingMember" id="dmpi_UnderwritingOfferingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="UnderwrittenPublicOfferingDescription" id="dmpi_UnderwrittenPublicOfferingDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="UnrecognizedCompensationExpenseTerm" id="dmpi_UnrecognizedCompensationExpenseTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="UsAndCanadianMember" id="dmpi_UsAndCanadianMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="USFederalCorporateTaxRate" id="dmpi_USFederalCorporateTaxRate" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ValentTechnologiesLlcAgreementsAbstract" id="dmpi_ValentTechnologiesLlcAgreementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ValentTechnologiesLlcMember" id="dmpi_ValentTechnologiesLlcMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ValentTechnologiesLlcTextBlock" id="dmpi_ValentTechnologiesLlcTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="VotingShare" id="dmpi_VotingShare" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantIssuedForServices" id="dmpi_WarrantIssuedForServices" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsDescription" id="dmpi_WarrantsDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsExercisableDescription" id="dmpi_WarrantsExercisableDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsExercised" id="dmpi_WarrantsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsExerciseTerm" id="dmpi_WarrantsExerciseTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsExpirationDate" id="dmpi_WarrantsExpirationDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsExpired" id="dmpi_WarrantsExpired" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsIssuedForServicesShare" id="dmpi_WarrantsIssuedForServicesShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsIssuedForServicesValue" id="dmpi_WarrantsIssuedForServicesValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsToPurchaseCommonStock" id="dmpi_WarrantsToPurchaseCommonStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
</schema>

12 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/13/24  Kintara Therapeutics, Inc.        S-4                   28:10M                                    Donnelley … Solutions/FA
10/27/23  Kintara Therapeutics, Inc.        S-1/A                 12:1.2M                                   Donnelley … Solutions/FA
10/24/23  Kintara Therapeutics, Inc.        S-1/A                 20:2.4M                                   Donnelley … Solutions/FA
10/04/23  Kintara Therapeutics, Inc.        S-1                   13:1.1M                                   Donnelley … Solutions/FA
 9/18/23  Kintara Therapeutics, Inc.        10-K        6/30/23   75:12M                                    Donnelley … Solutions/FA
 9/27/22  Kintara Therapeutics, Inc.        10-K        6/30/22   79:15M                                    Donnelley … Solutions/FA
 9/28/21  Kintara Therapeutics, Inc.        10-K        6/30/21   79:13M                                    ActiveDisclosure/FA
10/26/20  Kintara Therapeutics, Inc.        S-3                    4:1.5M                                   ActiveDisclosure/FA
 9/18/20  Kintara Therapeutics, Inc.        10-K        6/30/20   71:9.9M                                   ActiveDisclosure/FA
 9/01/20  Kintara Therapeutics, Inc.        8-K:1,3,5,7 8/31/20    4:300K                                   EdgarAgents LLC/FA
 8/25/20  Kintara Therapeutics, Inc.        8-K:1,3,5,7 8/20/20    4:190K                                   EdgarAgents LLC/FA
 8/21/20  Kintara Therapeutics, Inc.        8-K:1,2,3,5 8/17/20    8:1.4M                                   EdgarAgents LLC/FA
↑Top
Filing Submission 0001193125-20-185478   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., May 16, 5:17:38.1am ET